Cowagarcinone E



Compound IDCDAMM01168
Common nameCowagarcinone E
IUPAC name[4-[8-(3,7-dimethylocta-2,6-dienyl)-1,3,6-trihydroxy-7-methoxy-9-oxoxanthen-2-yl]-2-methylbut-2-enyl] acetate
Molecular formulaC31H36O8

Experimental data

Retention time0.41
Adduct[M+Na]+
Actual mz559.23
Theoretical mz559.23
Error1.11
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.7249

Identifiers and class information

Inchi keyUOQPQEKMOLGUPY-PAUOAVIZSA-N
SmilesO=C(OCC(=CCC1=C(O)C=C2OC3=CC(O)=C(OC)C(=C3C(=O)C2=C1O)CC=C(C)CCC=C(C)C)C)C
SuperclassOrganoheterocyclic compounds
ClassBenzopyrans

Pharmacokinetic properties

Number of descriptor values(#stars)2
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)13
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)536.621
Computed dipole moment(dipole)7.116
Total solvent accessible surface area (SASA)846.931
Hydrophobic component of SASA (FOSA)528.679
Hydrophilic component of SASA (FISA)187.612
Pie component of the SASA (PISA)130.64
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1651.72
Number of hydrogen bond donors (donorHB)2
Number of hydrogen bond acceptors (accptHB)6.5
Free energy of solvation of dipole (dip^2/V)0.0306566
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0108538
Globularity descriptor (glob)0.797888
Predicted polarizability in cubic angstroms (QPpolrz)52.848
Predicted hexadecane/gas partition coefficient (QPlogPC16)16.218
Predicted octanol/gas partition coefficient (QPlogPoct)24.396
Predicted water/gas partition coefficient (QPlogPw)10.386
Predicted octanol/water partition coefficient (QPlogPo/w)5.642
Predicted aqueous solubility (QPlogS)-7.028
Conformation-independent predicted aqueous solubility (CIQPlogS)-8.301
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.425
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)164.732
Predicted brain/blood partition coefficient (QPlogBB)-2.185
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)70.434
Predicted skin permeability, log Kp (QPlogKp)-3.269
PM3 calculated ionization potential (IP(ev))9.181
PM3 calculated electron affinity (EA(eV))0.596
Number of likely metabolic reactions (#metab)13
Prediction of binding to human serum albumin (QPlogKhsa)1.223
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)73.738
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)134.361
Number of nitrogen and oxygen atoms (#NandO)8
Number of violations of Lipinski’s rule of five (RuleOfFive)2
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P19838NFKB1Nuclear factor NF-kappa-B p105 subunitT83145SEA
P09917ALOX5Arachidonate 5-lipoxygenaseT00140SEA
P19838NFKB1Nuclear factor NF-kappa-B p105 subunitT83145SEA
P20839IMPDH1Inosine-5'-monophosphate dehydrogenase 1T40111SEA
P12268IMPDH2Inosine-5'-monophosphate dehydrogenase 2T89360SEA
P30307CDC25CDual specificity phosphatase Cdc25CT40569SEA
O60911CTSVCathepsin (V and K)T93653SEA
Q13332PTPRSReceptor-type tyrosine-protein phosphatase ST10147SEA
P16220CREB1Cyclic AMP-responsive element-binding proteinT92098SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T83145DI0218Irritable bowel syndrome[ICD-11: DD91]P19838NFKB1
T83145DI0366Rheumatoid arthritis[ICD-11: FA20]P19838NFKB1
T00140DI0037Asthma[ICD-11: CA23]P09917ALOX5
T00140DI0147Filariasis[ICD-11: 1F66]P09917ALOX5
T00140DI0403Thrombocytopenia[ICD-11: 3B64]P09917ALOX5
T83145DI0218Irritable bowel syndrome[ICD-11: DD91]P19838NFKB1
T83145DI0366Rheumatoid arthritis[ICD-11: FA20]P19838NFKB1
T40111DI0062Breast cancer[ICD-11: 2C60-2C6Y]P20839IMPDH1
T40111DI0179Hepatitis virus infection[ICD-11: 1E50-1E51]P20839IMPDH1
T40111DI0250Mature B-cell lymphoma[ICD-11: 2A85]P20839IMPDH1
T40111DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P20839IMPDH1
T40111DI0413Transplant rejection[ICD-11: NE84]P20839IMPDH1
T89360DI0413Transplant rejection[ICD-11: NE84]P12268IMPDH2
T93653DI0055Bone cancer[ICD-11: 2B5Z]O60911CTSV
T93653DI0087Chronic pain[ICD-11: MG30]O60911CTSV
T10147DI0057Bone paget disease[ICD-11: FB85]Q13332PTPRS

Copyright © 2025